✦ LIBER ✦

Clinical Significance of Recent Lipid Trials on Reducing Risk in Patients with Type 2 Diabetes Mellitus

✍ Scribed by Peter H. Jones

Book ID: 113443659
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 236 KB
Volume: 99
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2006.11.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical impact of reducing microalbumin

Clinical impact of reducing microalbuminuria in patients with type 2 diabetes mellitus

✍ Shin-ichi Araki; Masakazu Haneda; Daisuke Koya; Atsunori Kashiwagi; Takashi Uzu; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 292 KB

Individualizing Glycemic Targets in Type

Individualizing Glycemic Targets in Type 2 Diabetes Mellitus: Implications of Recent Clinical Trials

✍ Ismail-Beigi, Faramarz; Moghissi, Etie; Tiktin, Margaret; Hirsch, Irl B.; Inzucc 📂 Article 📅 2011 🏛 American College of Physicians 🌐 English ⚖ 130 KB

Lipid peroxidation in erythrocytes of pa

Lipid peroxidation in erythrocytes of patients with type 2 diabetes mellitus

✍ P. Ashok Kumar; G. Rajagopal 📂 Article 📅 2003 🏛 Association of Clinical Biochemistry of India 🌐 English ⚖ 241 KB

The impact of serum lipids on risk for m

The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus

✍ Peter P Toth, Robert J Simko, Swetha Rao Palli, Dawn Koselleck, Ralph A Quimbo, 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 318 KB

Benefits of lipid-lowering therapy in pa

Benefits of lipid-lowering therapy in patients with type 2 diabetes mellitus

✍ John Betteridge 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 205 KB

Risk of acute renal failure in patients

Risk of acute renal failure in patients with Type 2 diabetes mellitus

✍ C. J. Girman; T. D. Kou; K. Brodovicz; C. M. Alexander; E. A. O’Neill; S. Engel; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB